11.10.2017 17:40:05

Range Resources Overweight

Der Analyst Barclays Capital hat Range Resources Corp. von Underweight auf "Overweight" hochgestuft und das Kursziel von 18 auf 24 USD angehoben.
Zusammenfassung: Range Resources Corp. overweight
Unternehmen:
Range Resources Corp.
Analyst:
Barclays Capital
Kursziel:
24.00 $
Rating jetzt:
overweight
Kurs*:
19.68 $
Abst. Kursziel*:
21.95%
Rating update:
upgrade
Kurs aktuell:
18.86 $
Abst. Kursziel aktuell:
27.25%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Analysen zu Range Resources Corp.mehr Analysen

11.10.17 Range Resources overweight Barclays Capital
14.07.17 Range Resources Market Perform BMO Capital Markets
30.03.17 Range Resources Buy UBS AG
06.02.17 Range Resources Buy Instinet
25.01.17 Range Resources Buy R. F. Lafferty

Eintrag hinzufügen

Aktien in diesem Artikel

Range Resources Corp. 18.86 -0.74% Range Resources Corp.

Aktuelle Aktienanalysen

20.10.17 Imperial Capital
Mammoth Energy Services Outperform
20.10.17 Deutsche Bank AG
Sinclair Broadcast Grou a Buy
20.10.17 Deutsche Bank AG
Nexstar Broadcasting Group Buy
20.10.17 S&P Capital IQ
Unilever Hold
20.10.17 S&P Capital IQ
Unilever Hold
20.10.17 Credit Suisse Group
SAP Outperform
20.10.17 Kepler Cheuvreux
VTG buy
20.10.17 BMO Capital Markets
Five Prime Therapeutics Outperform
20.10.17 BMO Capital Markets
Chevron Market Perform
20.10.17 BMO Capital Markets
HAIN CELESTIAL GROUP Market Perform
20.10.17 BMO Capital Markets
Signature Ban Outperform
20.10.17 BMO Capital Markets
WellCare Health Plans Outperform
20.10.17 BMO Capital Markets
Universal Health Services Outperform
20.10.17 BMO Capital Markets
UnitedHealth Outperform
20.10.17 BMO Capital Markets
Molina Healthcare Market Perform
20.10.17 BMO Capital Markets
Mednax Market Perform
20.10.17 BMO Capital Markets
LifePoint Hospitals Market Perform
20.10.17 BMO Capital Markets
Humana Outperform
20.10.17 BMO Capital Markets
HCA Outperform
20.10.17 BMO Capital Markets
Cigna Market Perform
20.10.17 BMO Capital Markets
Centene Outperform
20.10.17 BMO Capital Markets
Anthem Market Perform
20.10.17 BMO Capital Markets
Universal Forest Products Market Perform
20.10.17 Imperial Capital
Proofpoint Outperform
20.10.17 Barclays Capital
Telefonica Equal weight
20.10.17 Barclays Capital
Seattle Genetics overweight
20.10.17 Barclays Capital
Regeneron Pharmaceuticals Underweight
20.10.17 UBS AG
Celgene Buy
20.10.17 DZ BANK
DEUTZ kaufen
20.10.17 UBS AG
Hewlett Packard Enterprise Neutral
20.10.17 Standpoint Research
DS a Buy
20.10.17 Wedbush Morgan Securities Inc.
Skechers USA Outperform
20.10.17 Morgan Stanley
Novo Nordisk Equal-Weight
20.10.17 Morgan Stanley
Roche Equal-Weight
20.10.17 Morgan Stanley
Novartis overweight
20.10.17 Morgan Stanley
Philips Lighting Equal-Weight
20.10.17 Deutsche Bank AG
McDonalds buy
20.10.17 Morgan Stanley
Michelin (Compagnie Générale d Etablissements Michelin SCPA) overweight
20.10.17 Morgan Stanley
AstraZeneca Equal-Weight
20.10.17 S&P Capital IQ
ASML NV Hold
20.10.17 Independent Research GmbH
Daimler Halten
20.10.17 JP Morgan Chase & Co.
Ericsson (Telefon AB LMEricsson) (B) Neutral
20.10.17 S&P Capital IQ
Reckitt Benckiser neutral
20.10.17 Goldman Sachs Group Inc.
Alphabet A (ex Google) Conviction Buy
20.10.17 JP Morgan Chase & Co.
General Electric Underweight
20.10.17 Goldman Sachs Group Inc.
Facebook buy
20.10.17 UBS AG
Unilever Neutral
20.10.17 UBS AG
Michelin (Compagnie Générale d Etablissements Michelin SCPA) buy
20.10.17 UBS AG
Hannover Rück Neutral
20.10.17 Gabelli & Co
TechnipFMC Buy